Answer
The safety and efficacy of IMDYLLTRA (tarlatamab) in children aged 18 years or younger have not yet been established.
Sources for this answer
- IMDYLLTRA 1 milligram powder for concentrate and solution for solution for infusionAmgen Ltd · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated
Sources checked